Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
8.58
-0.28 (-3.16%)
Nov 20, 2024, 4:00 PM EST - Market closed
Actuate Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 4.58 | 3.27 | 3.82 |
| Research & Development | 21.64 | 21.71 | 16.39 |
| Operating Expenses | 26.22 | 24.97 | 20.21 |
| Operating Income | -26.22 | -24.97 | -20.21 |
| Interest Expense | -0.02 | -0.04 | -0.02 |
| Interest & Investment Income | 0.16 | 0.35 | 0.03 |
| Other Non Operating Income (Expenses) | -0.13 | -0.08 | 0.04 |
| Pretax Income | -28.45 | -24.74 | -20.16 |
| Net Income | -28.45 | -24.74 | -20.16 |
| Net Income to Common | -28.45 | -24.74 | -20.16 |
| Shares Outstanding (Basic) | 4 | 1 | 1 |
| Shares Outstanding (Diluted) | 4 | 1 | 1 |
| Shares Change (YoY) | 218.96% | 18.53% | - |
| EPS (Basic) | -7.37 | -17.24 | -16.65 |
| EPS (Diluted) | -7.37 | -17.24 | -16.65 |
| Free Cash Flow | -22.58 | -21.63 | -17.79 |
| Free Cash Flow Per Share | -5.85 | -15.07 | -14.70 |
| EBIT | -26.22 | -24.97 | -20.21 |
Source: S&P Capital IQ. Standard template.
Financial Sources.